Quantcast

Latest Genmab Stories

2014-08-12 16:27:58

COPENHAGEN, Denmark, Aug. 12, 2014 /PRNewswire/ -- Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, today announced that it has appointed Jan van de Winkel, Ph.D, President and Chief Executive Officer of Genmab, to its Board of Directors, effective immediately. "We are pleased to add Jan to our Board," said Florian Schonharting, Forward Pharma's Co-Founder and Chairman of the Board of...

2014-07-28 12:27:31

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly,...

2014-06-10 16:27:52

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antibody Partnering Terms and Agreementshttp://www.reportbuyer.com/countries/north_america/usa/antibody_partnering_terms_agreements.html The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.The Antibody Partnering Terms and...

2014-06-03 11:18:46

Ohio State University Wexner Medical Center In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly outperformed ofatumumab as a second-line therapy, according to a multicenter interim study published in the OnLine First edition of the New England Journal of Medicine. Ibrutinib (Imbruvica) is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential...

2014-04-17 16:27:38

LONDON, April 17, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra(®) (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered...

2014-04-03 12:28:49

TUCSON, Ariz., April 3, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Genmab A/S, Copenhagen, Denmark for the development of companion diagnostic tools for Genmab's HuMax-TF®-ADC antibody drug conjugate (ADC) program. As part of the agreement, Ventana will provide its expertise and services towards the development of an immunohistochemistry (IHC) companion diagnostic test for the...

2014-04-03 08:21:56

DUBLIN, Apr. 03, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zvzsf4/antibodydrug ) has announced the addition of the "Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The report entitled 'Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis' is based on the evaluation of more than 90 companies. The report...

2014-03-13 16:27:58

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/43nvqj/cancer_monoclonal) has announced the addition of the "Cancer Monoclonal Antibodies Market Forecast to 2017" [http://www.researchandmarkets.com/research/43nvqj/cancer_monoclonal ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cancer, one of the leading causes of death worldwide, affected approximately 13 Million...

2014-01-29 16:28:33

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ztm9m5/antibodydrug) has announced the addition of the "Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis" [http://www.researchandmarkets.com/research/ztm9m5/antibodydrug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The report entitled 'Antibody-Drug Conjugates 2014 - A Business,...

2013-08-26 23:18:26

Transparency Market Research adds new "Antibody Drugs Market - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018" market research report to its report store. Browse report at http://www.transparencymarketresearch.com/antibody-drugs.html. Albany, New York (PRWEB) August 26, 2013 Antibody drugs make use of the body’s own immune system to locate and eliminate cells which are responsible for the target disease. Antibody drugs have been successful in...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related